151 related articles for article (PubMed ID: 16857742)
1. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
Yeh CW; Huang SS; Lee RP; Yung BY
Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
[TBL] [Abstract][Full Text] [Related]
2. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
Lin CY; Liang YC; Yung BY
Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53.
Chan HJ; Weng JJ; Yung BY
Biochem Biophys Res Commun; 2005 Jul; 333(2):396-403. PubMed ID: 15950182
[TBL] [Abstract][Full Text] [Related]
4. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N; Hill AD; Young LS
J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic role of nucleophosmin/B23.
Yung BY
Chang Gung Med J; 2007; 30(4):285-93. PubMed ID: 17939258
[TBL] [Abstract][Full Text] [Related]
6. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
8. c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells.
Yung BY
FEBS Lett; 2004 Dec; 578(3):211-6. PubMed ID: 15589822
[TBL] [Abstract][Full Text] [Related]
9. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.
Tsui KH; Juang HH; Lee TH; Chang PL; Chen CL; Yung BY
Acta Pharmacol Sin; 2008 Mar; 29(3):364-70. PubMed ID: 18298902
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin/B23 regulates PCNA promoter through YY1.
Weng JJ; Yung BY
Biochem Biophys Res Commun; 2005 Sep; 335(3):826-31. PubMed ID: 16099430
[TBL] [Abstract][Full Text] [Related]
11. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
13. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.
Hsu CY; Yung BY
Oncogene; 1998 Feb; 16(7):915-23. PubMed ID: 9484783
[TBL] [Abstract][Full Text] [Related]
15. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
Liu WH; Yung BY
Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708
[TBL] [Abstract][Full Text] [Related]
16. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
18. G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells.
Cogoi S; Quadrifoglio F; Xodo LE
Biochemistry; 2004 Mar; 43(9):2512-23. PubMed ID: 14992588
[TBL] [Abstract][Full Text] [Related]
19. MAP kinase additively activates the mouse Per1 gene promoter with CaM kinase II.
Nomura K; Takeuchi Y; Fukunaga K
Brain Res; 2006 Nov; 1118(1):25-33. PubMed ID: 17020748
[TBL] [Abstract][Full Text] [Related]
20. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
